Trial
NCT03190798
Effects of Canagliflozin on Intravascular Volume and Hemodynamics
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Janssen Scientific Affairs, LLC
Condition
Type2 Diabetes Mellitus
Intervention
Canagliflozin 300mg
Why stopped
Study has been withdrawn from IRB review pending IND revision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-12